Results 1 to 10 of about 4,512,082 (135)

Treatment Outcomes for Primary Hepatic Angiosarcoma: National Cancer Database Analysis 2004–2014 [PDF]

Current Oncology, 2022
Background: To determine the risk of mortality and factors associated with survival amongst patients diagnosed with primary hepatic angiosarcoma (PHA).
Ankit Mangla, Gino Cioffi, Jill S. Barnholtz-Sloan, Richard T. Lee   +3 more
doaj   +5 more sources

Case of Primary Hepatic Angiosarcoma Presenting With Jaundice and Infiltrative Liver Masses [PDF]

Journal of Investigative Medicine High Impact Case Reports, 2022
Primary hepatic angiosarcoma (PHA) is a rare and aggressive mesenchymal liver tumor with a poor prognosis and high mortality. Treatment options are limited to palliative chemotherapy with surgical resection reserved for the few cases that present early ...
Adnan Shaaban MD, Chimaobi Anugwom MBBS, Alma Habib MD, Tetyana Mettler MD, Shahid Jaffer MD, Mary Thomson MD   +5 more
doaj   +3 more sources

Primary hepatic angiosarcoma with noncirrhotic portal hypertension: A case report [PDF]

Frontiers in Oncology, 2023
BackgroundPrimary hepatic angiosarcoma (PHA) is a rare malignant tumor of mesothelial tissue origin in the liver. The diagnosis of PHA relies on pathology, and it is frequently misdiagnosed as multiple hepatic hemangioma. Noncirrhotic portal hypertension
Xuwei Wu, Xia Yu, Qiaorong Gan, Bin Wang, Zhaowang Lin, Yu Shi, Zuxiong Huang   +6 more
doaj   +4 more sources

Acute rupture of primary hepatic angiosarcoma with Kasabach-Merritt syndrome: a rare case report and literature review [PDF]

World Journal of Surgical Oncology
Background Primary hepatic angiosarcoma (PHA) is an extremely rare malignant tumor originating from vascular endothelial cells, accounting for only 0.1-2% of primary liver malignancies. Kasabach-Merritt syndrome (KMS) is a rare complication characterized
Lin Ye, Wanrong Yue, Hao Shi, Renjian Li, Jun Weng, Haozhe Zhou, Yaqun Yu   +6 more
doaj   +3 more sources

Primary Hepatic Angiosarcoma: Distinct Imaging Phenotypes Mirroring Histopathologic Growth Patterns in a Retrospective Human Study [PDF]

Diagnostics
Background/Objectives: To date, no studies have examined radiologic findings by histologic patterns of primary hepatic angiosarcoma; this study clarified radiologic findings of primary hepatic angiosarcoma according to distinct histologic patterns ...
Byoung Je Kim, Jung Hee Hong, Hye Won Lee   +2 more
doaj   +3 more sources

Surgical therapy of primary hepatic angiosarcoma [PDF]

BMC Surgery, 2019
Background Primary hepatic angiosarcoma (PHA) is a rare tumor entity. Radical surgical resection is currently considered the best treatment choice. The aim of this analysis is to report our experience with surgery for PHA.
Verena Tripke, Stefan Heinrich, Tobias Huber, Jens Mittler, Maria Hoppe-Lotichius, Beate K. Straub, Hauke Lang   +6 more
doaj   +3 more sources

The diagnostic dilemma of sinusoidal-type primary hepatic angiosarcoma: A case report and literature review [PDF]

Frontiers in Oncology
BackgroundPrimary hepatic angiosarcoma (PHA) is a rare, highly aggressive, and rapid progressive malignant liver tumor, of which the sinusoidal growth pattern represents one of its uncommon morphological subtypes.
Linfei Dong, Jinghang Xu, Ke Wang, Hui Liu, Li Liang, Huimin Ma, Yan Wang, Na Huo   +7 more
doaj   +4 more sources

Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis. [PDF]

PLoS ONE, 2019
OBJECTIVE:Primary hepatic angiosarcoma (PHA) is extremely rare and most patients die within 12 months of diagnosis. The object of the study is to determine the association of initial clinical-radiological features and staging with outcomes in patients ...
Wei-Hsin Yuan, Anna Fen-Yau Li, Hui-Chen Hsu, Yong-Sin Hu, Rheun-Chuan Lee   +4 more
doaj   +3 more sources

Clinical characteristics and surgical treatments of primary hepatic angiosarcoma [PDF]

BMC Gastroenterology, 2021
Purpose Primary hepatic angiosarcoma is a very rare and highly malignant tumor with poor prognosis. It is difficult to diagnose because of the lack of typical clinical features, and the treatment protocols for PHA are also not clear.
Lei Jiang, Lijun Xie, Ge Li, Hang Xie, Zhao Fang, Xinran Cai, Yanling Chen   +6 more
doaj   +2 more sources

Primary Hepatic Angiosarcoma: A Rare Liver Malignancy – Varying Manifestations but Grave Prognosis [PDF]

Case Reports in Gastroenterology, 2020
Primary hepatic angiosarcoma (PHA) is a rare mesenchymal liver tumor, accounting for 0.1–2% of primary liver malignancies. The clinical presentations of PHA are variable, from asymptomatic to liver failure or complicated with tumor rupture. The diagnosis
Natthapat Rujeerapaiboon, Panu Wetwittayakhlang   +1 more
doaj   +2 more sources